These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20298927)

  • 1. Reperfusion injury putting the genie back in the bottle?
    Reichek N; Parcham-Azad K
    J Am Coll Cardiol; 2010 Mar; 55(12):1206-1208. PubMed ID: 20298927
    [No Abstract]   [Full Text] [Related]  

  • 2. Acidic buffer or plus cyclosporine A post-conditioning protects isolated rat hearts against ischemia-reperfusion injury.
    Duan X; Ji B; Yu K; Hei F; Liu J; Long C
    Perfusion; 2011 May; 26(3):245-52. PubMed ID: 21490080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of permeability transition and myocardic reperfusion damage by cyclosporine A].
    Chávez E; García N; Pavón N
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-77-81. PubMed ID: 18938702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effects of cyclosporine A in an in vivo model of myocardial ischemia and reperfusion.
    Xie JR; Yu LN
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):909-13. PubMed ID: 17578461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine A, 2.5 mg/kg, does not reduce myocardial infarct size in a porcine model of ischemia and reperfusion.
    Karlsson LO; Bergh N; Grip L
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):159-63. PubMed ID: 21572075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats.
    Squadrito F; Altavilla D; Squadrito G; Saitta A; Campo GM; Arlotta M; Quartarone C; Ferlito M; Caputi AP
    Eur J Pharmacol; 1999 Jan; 364(2-3):159-68. PubMed ID: 9932719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism for cyclosporine: inhibition of myocardial ischemia and reperfusion injury in a heterotopic rabbit heart transplant model.
    Gatewood LB; Larson DF; Bowers MC; Bond S; Cardy A; Sethi GK; Copeland JG
    J Heart Lung Transplant; 1996 Sep; 15(9):936-47. PubMed ID: 8889990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine.
    Niemann CU; Saeed M; Akbari H; Jacobsen W; Benet LZ; Christians U; Serkova N
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1123-8. PubMed ID: 12183671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CardioPulse: Cyclosporine to reduce myocardial infarction injury?
    Nicholls M
    Eur Heart J; 2016 Jan; 37(3):210-1. PubMed ID: 27471760
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of cyclosporine A use in the prevention of reperfusion injury in acute myocardial infarction: A meta-analysis.
    Upadhaya S; Madala S; Baniya R; Subedi SK; Saginala K; Bachuwa G
    Cardiol J; 2017; 24(1):43-50. PubMed ID: 27734457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A.
    Liu L; Zhu J; Brink PR; Glass PS; Rebecchi MJ
    Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closing the pore on reperfusion injury: myocardial protection with cyclosporine.
    Muehlschlegel JD
    Anesthesiology; 2014 Aug; 121(2):212-3. PubMed ID: 24895914
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cyclosporine A: from immunomodulation to prevention of ischemia-reperfusion injuries].
    Gennai S; Pison C; Briot R
    Ann Fr Anesth Reanim; 2013 Dec; 32(12):886-7. PubMed ID: 24199903
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction.
    Mewton N; Croisille P; Gahide G; Rioufol G; Bonnefoy E; Sanchez I; Cung TT; Sportouch C; Angoulvant D; Finet G; André-Fouët X; Derumeaux G; Piot C; Vernhet H; Revel D; Ovize M
    J Am Coll Cardiol; 2010 Mar; 55(12):1200-1205. PubMed ID: 20298926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effects of low-dose cyclosporin A added to histidine-tryptophan-ketoglutarate cardioplegia solution prior to total myocardial ischemia: an in vitro rabbit heart study.
    Pritzwald-Stegmann P; Hoyer A; Kempfert J; Dhein S; Mohr FW
    Pharmacology; 2011; 88(3-4):167-73. PubMed ID: 21952163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Cyclosporine on Reperfusion Injury in Patients: A Meta-Analysis of Randomized Controlled Trials.
    Song K; Wang S; Qi D
    Oxid Med Cell Longev; 2015; 2015():287058. PubMed ID: 26167239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postconditioning in acute myocardial infarction patients.
    Ivanes F; Rioufol G; Piot C; Ovize M
    Antioxid Redox Signal; 2011 Mar; 14(5):811-20. PubMed ID: 20578963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine protects the heart during aortic valve surgery.
    Chiari P; Angoulvant D; Mewton N; Desebbe O; Obadia JF; Robin J; Farhat F; Jegaden O; Bastien O; Lehot JJ; Ovize M
    Anesthesiology; 2014 Aug; 121(2):232-8. PubMed ID: 25050491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine A cardioprotection: mechanisms and potential for clinical application.
    Bünger R; Mallet RT
    Crit Care Med; 2013 Apr; 41(4):1156-8. PubMed ID: 23528770
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic type-I diabetes could not impede the anti-inflammatory and anti-apoptotic effects of combined postconditioning with ischemia and cyclosporine A in myocardial reperfusion injury.
    Badalzadeh R; Azimi A; Alihemmati A; Yousefi B
    J Physiol Biochem; 2017 Feb; 73(1):111-120. PubMed ID: 27771871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.